HempNewsBreaks

ThursdayMay 16, 2024 3:30 pm

HempNewsBreaks – Lexaria Bioscience Corp. (NASDAQ: LEXX) Looking to Tap into Various Growing Markets

Lexaria Bioscience Corp. (NASDAQ: LEXX), a global innovator in drug delivery platforms, has proven in numerous studies the ability of its patented DehydraTECH(TM) technology to increase bio-absorption compared to standard industry formulations, as well as reduce time of onset and deliver drugs more effectively across the blood-brain barrier. “DehydraTECH has a number of potential pharmaceutical applications, a testament to its versatility and overall effectiveness. The key factor that has played a role in its adoption is its unique ability to improve drug bioavailability, a critical marker and determinant of overall drug effectiveness,” a recent article reads. “With this technology, Lexaria…

Continue Reading

WednesdayMay 15, 2024 3:55 pm

HempNewsBreaks – Golden Triangle Ventures Inc. (GTVH) Journeys Toward Creation of One-of-a-Kind Destination

Golden Triangle Ventures (OTC: GTVH) is a multifaceted consulting company that operates as a parent business pursuing ventures in the health, entertainment and technology sectors. GTVH and its entertainment division, Lavish Entertainment, are working with Cayenne Consulting on the strategic development of Destino Ranch. “Destino Ranch aims to redefine luxury entertainment and hospitality experiences. Set amid the breathtaking landscapes of the Mojave Desert, Destino Ranch will offer a unique blend of world-class entertainment, luxurious accommodations and immersive experiences. The destination location is designed to be an outdoor music and festival venue, immersive art installation and tourist attraction,” a recent article…

Continue Reading

TuesdayMay 14, 2024 3:37 pm

HempNewsBreaks – Zoned Properties Inc. (ZDPY) Releases Q1 2024 Financial Results Showing 22% Revenue Growth

Zoned Properties (OTCQB: ZDPY), a technology-driven property investment company for emerging and highly regulated industries, including legalized cannabis, released its financial results for Q1 2024, the period ended March 31; the company also noted recent business highlights. According to the report, financial highlights include revenues totaling $837,052 for the quarter ended March 31, 2024, compared to $688,024 million revenues for the same quarter 2023, representing an increase of 22%; net income of $96,473, or $0.01 per fully diluted share, as compared to a net loss of $309,648, or ($0.03) per fully diluted share, for the same quarter in 2023, representing…

Continue Reading

TuesdayMay 14, 2024 2:34 pm

HempNewsBreaks – Astrotech Corp. (NASDAQ: ASTC) Releases Q3 202 Financial Report

Astrotech (NASDAQ: ASTC), an innovative science and technology company, is reporting its financial results for the third quarter of fiscal year 2024, for the period ended March 31, 2024. Highlights of the report include the company’s strong consolidated balance sheet showing $34.7 million in cash and liquid investments; revenue for the year-to-date coming in at $1.6 million; year-to-date gross margin increased to 45% from 37% through the third quarter of fiscal year 2024; the company’s subsidiary, 1st Detect, accepting orders for the TRACER 1000 Narcotics Trace Detector (“NTD”); the TRACER 1000 being listed in the U.S. General Services Administration (“GSA”) IT…

Continue Reading

FridayMay 10, 2024 2:44 pm

HempNewsBreaks – CannaCon West to Propel Growth of Cannabis Industry in Western US

CannaCon, a leading conference company, is announcing the CannaCon West Albuquerque. The event is set to take place on May 17-18, 2024, at the stunning Albuquerque Convention Center, Albuquerque. CannaCon West Albuquerque is one of several national CannaCon expos. It is designed to propel the growth of the cannabis industry in the western U.S., reverberate nationally, and create lasting value for years to come. According to the announcement, the two-day event paves the way to building a new industry paradigm in the western region of the U.S. by offering dynamic entrepreneurs expertise in raising seed capital, business and legal advice,…

Continue Reading

ThursdayMay 09, 2024 11:57 am

HempNewsBreaks – Astrotech Corporation (NASDAQ: ASTC) Filling Void in Hemp and Cannabis Market

Astrotech (NASDAQ: ASTC), a science and technology development and commercialization company, and its wholly owned subsidiary, AgLAB Inc., have developed a mass spectrometer designed for use in the hemp and cannabis market. “During the process of converting cannabis biomass into distillate, valuable cannabinoids are typically lost, resulting in reduced profits. AgLAB’s Maximum Value Processing (‘MVP’) method uses the powerful AgLAB-1000-D2 mass spectrometer to test and to accurately configure the distillation system for optimal efficiency. The AgLAB MVP mass spectrometer and its rugged design are built to withstand the demands of the factory floor. The AgLAB-1000-D2 model offers real-time potency tests…

Continue Reading

WednesdayMay 08, 2024 2:17 pm

HempNewsBreaks – Lexaria Bioscience Corp. (NASDAQ: LEXX) Begins Dosing of Human Pilot Study No. 2, GLP-1-H24-2

Lexaria Bioscience (NASDAQ: LEXX, LEXXW), a global innovator in drug delivery platforms, today announced that its second human pilot study, GLP-1-H24-2, is underway and the first dosing visit for all nine study participants has concluded. The three-arm, crossover study will compare three 7 mg semaglutide dose formulations: A positive control Rybelsus(R) swallowed tablet (already dosed); DehydraTECH-semaglutide swallowed capsules; and, for the first time ever, an in-mouth dissolvable DehydraTECH-semaglutide oral tablet. According to the announcement, the second DehydraTECH study arm will use a Rybelsus(R) composition processed with DehydraTECH that is compliant with the U.S. Food and Drug Administration’s Inactive Ingredient Database…

Continue Reading

MondayMay 06, 2024 3:14 pm

HempNewsBreaks – Lexaria Bioscience Corp. (NASDAQ: LEXX) Launches New Research Program to Evaluate DehydraTECH-GLP-1 Drugs

Lexaria Bioscience (NASDAQ: LEXX, LEXXW), a global innovator in drug delivery platforms, has announced an applied research program to evaluate certain molecular characteristics of DehydraTECH processed with the glucagon-peptide 1 (“GLP-1”) drug, semaglutide, related to its mode of action and performance. According to the announcement, the research will be conducted in partnership with the National Research Council of Canada (“NRC”). “We are excited about our partnership with the NRC for the mode of action molecular characterization of DehydraTECH-GLP-1 drugs. This work program could potentially provide data to assist Lexaria’s efforts in partnering with the pharmaceutical industry for the most rapid…

Continue Reading

WednesdayMay 01, 2024 2:19 pm

HempNewsBreaks – Lexaria Bioscience Corp. (NASDAQ: LEXX) Announces $4.7M Warrant Exercise Agreement

Lexaria Bioscience (NASDAQ: LEXX, LEXXW), a global innovator in drug-delivery platforms, has entered into a warrant exercise agreement with an existing accredited investor to exercise in full existing warrants. Specifically, the agreement is comprised of the purchase of 2,917,032 shares of common stock, as to 1,618,330 warrants exercised at an exercise price of $0.97 per share, and 1,298,702 warrants exercised at $2.185 per share; the shares and warrants were originally issued in October 2023 and February 2024, respectively. The company noted that following this exercise, there are no remaining warrants exercisable at $0.97 and 259,741 warrants unexercised at $2.185. According…

Continue Reading

MondayApr 29, 2024 2:43 pm

HempNewsBreaks – Golden Triangle Ventures Inc. (GTVH) CEO Featured Guest in Most Recent Bell2Bell Podcast

Golden Triangle Ventures (OTC: GTVH), a multifaceted consulting company, is spotlighted in the latest episode of the Bell2Bell Podcast, released from IBN. During the interview, GTVH president and CEO Steffan Dalsgaard talks with Bell2Bell host Stuart Smith about the company and Destino Ranch, its flagship project designed to be a tourist attraction, large immersive art installation and music festival venue; the ranch will be located about an hour from Las Vegas. As part of the development, Golden Triangle Ventures has purchased 70 acres and acquired ABI Create, one of the largest event developers in the country. In addition, Dalsgaard noted…

Continue Reading